23andMe (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic alternatives,” which could include a potential sale of the company or a restructuring.
23andMe (ME), the company that popularized consumer genetic testing, announced Tuesday that it is once again exploring “strategic alternatives,” which could include a potential sale of the company or a restructuring.Read more…